"We live in a society exquisitely dependent on science and technology, in which hardly anyone knows anything about science and technology."
Carl Sagan
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7282578 | Nucleic acid molecule comprising a nucleic acid sequence which codes for a haemocyanin A nucleic acid molecule or construct alone or with a promoter suitable for expression control is contemplated that codes for a KLH1 haemocyanin, a haemocyanin domain or a fragment thereof with the immunological properties of at least one domain of haemocyanin, and c... | 10/16/2007 |
| 7273928 | Nucleic acid molecule comprising a nucleic acid sequence coding for a haemocyanin A nucleic acid molecule or construct alone or with a promoter suitable for expression control is contemplated that codes for a HLH2 haemocyanin polypeptide and comprises at least one intron sequence, as well as haemocyanin fusion proteins. The construct further can ... | 09/25/2007 |
| 7265217 | Recombinant mistletoe lectin The present invention relates to processes for the production of mistletoe lectin polypeptides in homologous and heterologous host systems and mistletoe lectin peptides. Further, nucleic acid molecules are provided, which encode these mistletoe lectin polypeptides, ... | 09/04/2007 |
| 6927207 | Recombinant mistletoe lectines The present invention relates to isolated mistletoe lectin polypeptides and the pharmaceutical composition comprising the polypeptides thereof. Also, the present invention relates to processes for the production of mistletoe lectin polypeptides in homologous and het... | 08/09/2005 |
| 6656509 | Combination of selenium-containing compounds with cytostatics The present invention relates to the use of selenium and/or a derivative thereof in combination with one or more cytostatics. It is the object of the present invention to provide a possibility of enhancing the effect of antitumor drugs, and to provide said dru... | 12/02/2003 |